Savient Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Savient Pharmaceuticals's estimated annual revenue is currently $7M per year.
- Savient Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Savient Pharmaceuticals has 35 Employees.
- Savient Pharmaceuticals grew their employee count by -3% last year.
Savient Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|
Savient Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is Savient Pharmaceuticals?
Savient Pharmaceuticals is a specialty biopharmaceutical company engaged in developing and commercializing pharmaceutical products that target unmet medical needs in rheumatology and other specialty niche medical markets. Our focus is on our novel biologic product candidate, KRYSTEXXA (pegloticase) for intravenous infusion.
keywords:N/A
N/A
Total Funding
35
Number of Employees
$7M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.6M | 35 | -42% | N/A |
#2 | $6.8M | 35 | -10% | N/A |
#3 | $5.7M | 35 | -17% | N/A |
#4 | $6.9M | 35 | 0% | N/A |
#5 | $3.5M | 35 | -8% | N/A |